164 related articles for article (PubMed ID: 36030623)
1. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.
Lim ST; Murphy SJX; Murphy SM; Coughlan T; O'Neill D; Tierney S; Egan B; Collins DR; McCarthy AJ; Lim SY; Smith DR; Cox D; McCabe DJH
J Neurol Sci; 2022 Oct; 441():120334. PubMed ID: 36030623
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
3. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
[TBL] [Abstract][Full Text] [Related]
4. Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature.
Lim ST; Coughlan CA; Murphy SJ; Fernandez-Cadenas I; Montaner J; Thijs V; Marquardt L; McCabe DJ
Platelets; 2015; 26(5):402-12. PubMed ID: 26042726
[TBL] [Abstract][Full Text] [Related]
5. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
[TBL] [Abstract][Full Text] [Related]
6. Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Murphy SJX; Lim ST; Kinsella JA; Tierney S; Egan B; Feeley TM; Murphy SM; Walsh RA; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; Cox D; Moran N; Hamilton G; Meaney JF; McCabe DJH
J Neurol; 2020 Jan; 267(1):168-184. PubMed ID: 31606758
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Coughlan T; Collins DR; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
J Neurol; 2014 Jul; 261(7):1405-12. PubMed ID: 24781842
[TBL] [Abstract][Full Text] [Related]
9. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
J Neurol; 2013 Feb; 260(2):590-6. PubMed ID: 23064666
[TBL] [Abstract][Full Text] [Related]
11. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132
[TBL] [Abstract][Full Text] [Related]
14. Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Kinsella JA; Oliver Tobin W; Tierney S; Feeley TM; Egan B; Coughlan T; Ronan Collins D; O'Neill D; Harbison JA; Doherty CP; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Saqqur M; Murphy RP; Moran N; Hamilton G; McCabe DJH
J Neurol Sci; 2017 May; 376():133-139. PubMed ID: 28431600
[TBL] [Abstract][Full Text] [Related]
15. The association between high on-treatment platelet reactivity and early recurrence of ischemic events after minor stroke or TIA.
Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Wang Y; Cao Y
Neurol Res; 2017 Aug; 39(8):719-726. PubMed ID: 28398139
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
[TBL] [Abstract][Full Text] [Related]
17. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
[TBL] [Abstract][Full Text] [Related]
18. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis.
Fiolaki A; Katsanos AH; Kyritsis AP; Papadaki S; Kosmidou M; Moschonas IC; Tselepis AD; Giannopoulos S
J Neurol Sci; 2017 May; 376():112-116. PubMed ID: 28431593
[TBL] [Abstract][Full Text] [Related]
19. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
